Leila Alland is Director of ABEONA THERAPEUTICS INC.. Currently has a direct ownership of 118,265 shares of ABEO, which is worth approximately $674,110. The most recent transaction as insider was on Aug 26, 2024, when has been sold 11,797 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 118K
0% 3M change
64.58% 12M change
Total Value Held $674,110

Leila Alland Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 26 2024
BUY
Grant, award, or other acquisition
-
11,797 Added 9.07%
118,265 Common Stock
Jul 08 2024
BUY
Grant, award, or other acquisition
-
23,611 Added 18.15%
106,468 Common Stock
May 16 2024
BUY
Open market or private purchase
$51,810 $4.71 p/Share
11,000 Added 11.72%
82,857 Common Stock
Sep 27 2023
SELL
Open market or private sale
$28,259 $3.9 p/Share
7,246 Reduced 9.16%
71,857 Common Stock
Jun 14 2023
BUY
Grant, award, or other acquisition
$271,143 $4.62 p/Share
58,689 Added 42.59%
79,103 Common Stock
Sep 26 2022
BUY
Grant, award, or other acquisition
-
13,400 Added 39.63%
20,414 Common Stock
May 25 2021
BUY
Grant, award, or other acquisition
-
77,181 Added 50.0%
77,181 Common Stock

Also insider at

PMVP
PMV Pharmaceuticals, Inc. Healthcare
LA

Leila Alland

Director
Cranbury, NJ

Track Institutional and Insider Activities on ABEO

Follow ABEONA THERAPEUTICS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABEO shares.

Notify only if

Insider Trading

Get notified when an Abeona Therapeutics Inc. insider buys or sells ABEO shares.

Notify only if

News

Receive news related to ABEONA THERAPEUTICS INC.

Track Activities on ABEO